• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Quanterix

edit

Quanterix Corporation is developing a novel platform for single molecule analysis that will bring an unprecedented level of sensitivity, precision, and assay robustness to clinical diagnostics, drug development, and life science research. Their unique approach permits rapid quantification and analysis of individual proteins and small molecules within complex biological samples, enabling us to address a variety of unmet medical needs. Founded in 2007, Quanterix is backed by leading life science investors including ARCH Venture Partners, Bain Capital Ventures, and Flagship Ventures.

Milestones

edit

• 
  Quanterix added David Duffy, Ph.D. as Vice President of Research.
  Posted 11/18/12 at 6:29am
• 
  Quanterix added Ernest Orticerio as Vice President of Finance and Administration and CFO.
  Posted 11/18/12 at 6:29am
• 
  Quanterix added Paul Chapman as President and CEO.
  Posted 11/18/12 at 6:29am
• 
  Quanterix added Martin Madaus as CEO.
  Posted 9/19/11 at 6:34pm
• 
  Quanterix received $18.5M in Series C funding. (11/15/12)
  Posted 11/15/12 at 7:19pm via masshightech.com
• 
  Quanterix received $6M in Venture Round funding. (8/19/11)
  Posted 8/19/11 at 6:08pm via masshightech.com
• 
  Quanterix received $15M in Series A funding. (8/25/08)
  Posted 12/24/08 at 3:04am via equityhelpdesk.com
• 
  Quanterix — named former Millipore Corp. president and CEO Martin D. Madaus as executive chairman of the board. (12/1/10)
  Posted 12/2/10 at 3:25am via masshightech.com

Videos

Screenshots

edit

Traffic Analytics

Compete

Sources

1. Equity Help Desk (equityhelpdesk.com) [edit]
2. Quanterix collects $6M in new funding (masshightech.com) [edit]
3. Quanterix raises $18.5M, inks deal with bioMerieux (masshightech.com) [edit]
Former Millipore CEO Madaus joins Quanterix (masshightech.com) [edit]